Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | VNN1 | O95497 | 4/20 | 0.52 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.51 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.49 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.49 |
| ▸ | MEP1A | Q16819 | 1/20 | 0.49 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL534926 | 0.88 | FFAR1 (0.53) | FFAR1FFAR4VNN1ERCC1ERCC4 | |
| SCHEMBL3461756 | 0.81 | ERCC1 (0.60) | FFAR1FFAR4VNN1ERCC1ERCC4 | |
| SCHEMBL2489141 | 0.80 | SCN8A (0.51) | FFAR1VNN1ERCC1ERCC4DPP7 | |
| SCHEMBL5352838 | 0.80 | LOXL2 (0.53) | FFAR1VNN1 | |
| SCHEMBL29860036 | 0.79 | SCN8A (0.47) | FFAR1FFAR4VNN1ERCC1ERCC4 | |
| SCHEMBL3491515 | 0.79 | FFAR1 (0.72) | FFAR1FFAR4LMNA | |
| SCHEMBL335418 | 0.78 | LMNA (0.56) | FFAR1FFAR4VNN1ERCC1ERCC4 | |
| SCHEMBL5115918 | 0.78 | FFAR1 (0.52) | FFAR1FFAR4VNN1ERCC1ERCC4 | |
| SCHEMBL410123 | 0.78 | SCN8A (0.57) | VNN1ERCC1ERCC4DPP7MEP1B | |
| SCHEMBL30909992 | 0.77 | SCN8A (0.51) | FFAR1FFAR4VNN1ERCC1ERCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240182382-A1 | ALIPHATIC 18F-RADIOLABELING OF A TETRAZINE PRECURSOR | UNIV COPENHAGEN (DK) | 2024-06-06 | — | — | US | disclosed |
| EP-4305009-A2 | ALIPHATIC 18F-RADIOLABELING OF A TETRAZINE PRECURSOR | University of Copenhagen (DK) | 2024-01-17 | — | — | EP | disclosed |
| EP-2193125-B1 | OXADIAZOLE DERIVATIVES | MERCK SERONO SA (CH) | 2017-01-11 | — | — | EP | disclosed |
| US-8202865-B2 | Oxadiazole derivatives | MERCK SERONO SA (CH) | 2012-06-19 | — | — | US | disclosed |
| US-20100240658-A1 | Oxadiazole Derivatives | MERCK SERONO SA (CH) | 2010-09-23 | — | — | US | disclosed |
| EP-2193125-A2 | OXADIAZOLE DERIVATIVES | Merck Serono S.A. (CH) | 2010-06-09 | — | — | EP | disclosed |
| WO-2009043889-A2 | OXADIAZOLE DERIVATIVES | MERCK SERONO S.A. (CH) | 2009-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240182382-A1 | ALIPHATIC 18F-RADIOLABELING OF A TETRAZINE PRECURSOR | NBAS, HRAS, NAA15 | FFAR1 314/4885FFAR4 831/4885VNN1 748/4885 |
| US-20100240658-A1 | Oxadiazole Derivatives | OXA1L, RO60, NQO2 | FFAR1 2906/4885FFAR4 3301/4885VNN1 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.